Gene therapy for hemophilia has emerged as a revolutionary advancement in the treatment of this chronic bleeding disorder, offering new hope for patients who have spent years managing their condition.Traditionally reliant on frequent injections of clotting factor, individuals with hemophilia B, like Terence Blue, now have the potential to significantly reduce their dependence on these treatments.